 |
|
|
| |
Higher rates of virological relapse after nucleos(t)ide analogue withdrawal in HBeAg-negative versus positive
chronic hepatitis B patients: Results from a global, multi-ethnic cohort of patients with chronic hepatitis B virus infection
|
| |
| |
EASL 2022 June 22-26 London
Hannah S.J. Choi1, Grishma Hirode1,2,3, Chien-Hung Chen4, Tung-Hung Su5, Margarita Papatheodoridi6, Sabela Lens7, Stijn Van Hees8, Sylvia M. Brakenhoff9, Rong-Nan Chien10, Wai-Kay Seto11, Grace Wong12, Jordan Feld1, Henry LY Chan12, Man-Fung Yuen11,
Milan J. Sonneveld9, Thomas Vanwolleghem , Xavier Forns , George V. Papatheodoridis , Jia-Horng Kao5 Yao-Chun Hsu13, Markus Cornberg14, Bettina E. Hansen1,3, Wen-Juei Jeng10, Harry LA Janssen1
1 Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Canada; 2 Institute of Medical Science, University of Toronto, Canada; 3 The Toronto Viral Hepatitis Care Network (VIRCAN), Canada; 4 Kaohsiung Chang Gung Memorial Hospital, Taiwan; 5 National Taiwan University Hospital, Taiwan; 6 Medical School of National and Kapodistrian University of Athens, Greece; 7 Hospital Clinic Barcelona, IDIBAPS and CIBEREHD, University of Barcelona, Spain; 8 Department of Gastroenterology and Hepatology, Antwerp University Hospital, Antwerp, Belgium; 9 Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, Netherlands; 10 Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital Linkou Medical Center, Chang Gung University, Linkou, Taiwan; 11 Department of Medicine and State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong, SAR, China; 12 The Chinese University of Hong Kong, Hong Kong, SAR, China; 13 E-Da Hospital/I-Shou University, Kaohsiung, Taiwan; 14 Department of Gastroenterology, Hepatolology and Endocrinology, Hannover Medical School, Germany; Centre for Individualized Infection Medicine (CiiM), Hannover, Germany
|
| |
|
|
|
|
|
